J.W. Cole Advisors, Inc. Amgen Inc Transaction History

J.W. Cole Advisors, Inc.

$2.09 Billion
Q2 2024

A detailed history of J.W. Cole Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, J.W. Cole Advisors, Inc. holds 14,313 shares of AMGN stock, worth $4.83 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

14,313

Previous 9,616 48.85%

Holding current value

$4.83 Million

Previous $2.73 Million 63.57%

% of portfolio

0.21%

Previous 0.14%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$262.75 - $319.31 $1.23 Million - $1.5 Million	4,697 Added 48.85%	14,313 $4.47 Million
Q1 2024 Apr 30, 2024	BUY	$268.87 - $324.56 $50,547 - $61,017	188 Added 1.99%	9,616 $2.73 Million
Q4 2023 Jan 31, 2024	BUY	$255.7 - $288.46 $1.7 Million - $1.92 Million	6,643 Added 238.53%	9,428 $2.72 Million
Q3 2023 Oct 24, 2023	BUY	$218.65 - $271.46 $63,845 - $79,266	292 Added 11.71%	2,785 $748,000
Q2 2023 Jul 27, 2023	SELL	$214.27 - $253.37 $192,414 - $227,526	-898 Reduced 26.48%	2,493 $553,000
Q1 2023 May 03, 2023	BUY	$225.79 - $275.2 $4,290 - $5,228	19 Added 0.56%	3,391 $819,000
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $40,309 - $51,217	-176 Reduced 4.96%	3,372 $885,000
Q3 2022 Oct 31, 2022	BUY	$224.46 - $253.15 $86,866 - $97,969	387 Added 12.24%	3,548 $800,000
Q2 2022 Jul 27, 2022	SELL	$230.71 - $256.74 $113,278 - $126,059	-491 Reduced 13.44%	3,161 $769,000
Q1 2022 Jun 10, 2022	SELL	$219.27 - $242.57 $192 Million - $212 Million	-875,150 Reduced 99.58%	3,652 $883,000
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $192 Million - $212 Million	875,052 Added 23334.72%	878,802 $349,000
Q4 2021 Jan 25, 2022	SELL	$198.88 - $227.6 $39,179 - $44,837	-197 Reduced 4.99%	3,750 $844,000
Q3 2021 Oct 26, 2021	BUY	$212.27 - $248.7 $37,784 - $44,268	178 Added 4.72%	3,947 $839,000
Q2 2021 Aug 06, 2021	BUY	$233.58 - $259.14 $57,227 - $63,489	245 Added 6.95%	3,769 $919,000
Q1 2021 Apr 28, 2021	SELL	$221.91 - $258.6 $84,103 - $98,009	-379 Reduced 9.71%	3,524 $877,000
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $1.35 Million - $1.61 Million	-6,254 Reduced 61.57%	3,903 $897,000
Q3 2020 Nov 05, 2020	BUY	$234.65 - $260.95 $2.38 Million - $2.65 Million	10,157 New	10,157 $2.58 Million
Q1 2020 May 07, 2020	SELL	$182.24 - $241.7 $963,867 - $1.28 Million	-5,289 Closed	0 $0
Q4 2019 Jan 23, 2020	BUY	$189.21 - $243.2 $1 Million - $1.29 Million	5,289 New	5,289 $1.28 Million

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $180B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of J.W. Cole Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on J.W. Cole Advisors, Inc. with notifications on news.

Account

J.W. Cole Advisors, Inc. Amgen Inc Transaction History